ArticleCancer medicine2024

Favorable outcome of neoadjuvant endocrine treatment than surgery-first in female HR-positive/HER2-negative breast cancer patients-A NCDB analysis (2010-2016).

Peng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.